South China Biological Medicine (China)

Guangzhou South China Agricultural University Biological Medicine Co., Ltd. (South China Biological Medicine) is a high-tech enterprise with independent legal personality engaged in the research, development, production, sales and technical services of veterinary biological products for prevention, diagnosis and treatment. It is a designated production enterprise for highly pathogenic avian influenza vaccines by the Ministry of Agriculture. The company was established in December 2004 and is located in the high-tech industrial base of Zengcheng District, Guangzhou, covering an area of about 50 mu. It operates three GMP production workshops for avian influenza inactivated vaccines, embryo-derived inactivated vaccines and cell-derived inactivated vaccines, with an annual production capacity of 5 billion doses of various veterinary biological products. It has long-term cooperation with the College of Veterinary Medicine of South China Agricultural University and other institutions, and has developed multiple avian influenza vaccine products.

Guangzhou South China Agricultural University Biological Medicine Co., Ltd. was established in December 2004 and is located in the high-tech industrial base of Zengcheng District, Guangzhou, covering an area of about 50 mu. Since its establishment, it has cooperated closely with the College of Veterinary Medicine of South China Agricultural University, creating a new industry-university-research cooperation model. Together with South China Agricultural University, applying reverse genetics technology, it successfully developed products such as the recombinant avian influenza virus (H5+H7) trivalent inactivated vaccine (H5N2 rHN5801 strain + rGD59 strain, H7N9 rHN7903 strain), avian influenza virus H5 subtype inactivated vaccine (D7 strain + rD8 strain), and avian influenza inactivated vaccine (H5N2 subtype, D7 strain). The avian influenza inactivated vaccine (H5N2 subtype, D7 strain) obtained a new veterinary drug certificate from the Ministry of Agriculture in 2013 [(2013) New Veterinary Drug Certificate No. 12]; the avian influenza virus H5 subtype inactivated vaccine (D7 strain + rD8 strain) obtained a new veterinary drug certificate in 2017 [(2017) New Veterinary Drug Certificate No. 10]; the recombinant avian influenza virus (H5+H7) trivalent inactivated vaccine (H5N2 rHN5801 strain + rGD59 strain, H7N9 rHN7903 strain) obtained a new veterinary drug registration certificate in 2021 (Certificate No.: (2021) New Veterinary Drug Certificate No. 67). The company has also established the 'South China Biological Medicine Innovation Research Institute' and 'Academician Expert Enterprise Workstation', and has received titles such as 'High-tech Enterprise', 'National Model Academician Expert Enterprise Workstation', 'Guangdong Provincial Engineering Laboratory', 'Guangdong Provincial Engineering Technology Center', 'Guangdong Provincial Enterprise Technology Center', 'Guangdong Provincial SME Innovation Industrialization Demonstration Base', and 'Guangdong Provincial Key Leading Enterprise in Agriculture'.

High-tech enterprise and designated production enterprise for highly pathogenic avian influenza vaccines; aims to be an industry-leading value-creating enterprise providing quality products and best services through advanced technology and scientific management.

• Recombinant avian influenza virus (H5+H7) quadrivalent inactivated vaccine (H5N6 rHN503 strain + H5N1 rHN504 strain, H7N9 rHN705 strain + rHN706 strain)

• Recombinant avian influenza virus (H5 subtype) bivalent inactivated vaccine (H5N6 rHN503 strain + H5N1 rHN504 strain)

• Avian influenza (H9 subtype) inactivated vaccine

• Recombinant avian influenza virus (H5+H7) trivalent inactivated vaccine (H5N2 rHN5801 strain + rGD59 strain, H7N9 rHN7903 strain)

• Avian influenza inactivated vaccine (H9 subtype, SS strain)

• Newcastle disease virus (La Sota strain) and avian influenza virus (H9 subtype, SS strain) bivalent inactivated vaccine

• Newcastle disease virus, infectious bronchitis and avian influenza (H9 subtype) trivalent inactivated vaccine (La Sota strain + M41 strain + SS strain)

1. 1广州市华南农大生物药品有限公司 - 网站首页gzscbm.com
2. 2公司简介 - 广州市华南农大生物药品有限公司gzscbm.com
3. 3发展历程 - 广州市华南农大生物药品有限公司gzscbm.com
4. 4公司简介 - 广州市华南农大生物药品有限公司gzscbm.com
5. 5South China Biological Medicine (China)wikidata.org